Eli Lilly’s Ebglyss (lebrikizumab-lbkz) showed improvement in skin clearance and itch relief for most patients with ...

Their results argue for a change to parity between small-molecule agents and biologics when it comes to Inflation Reduction ...

Managed Healthcare Executive provides C-suite executives at health plans and provider organizations with news, analysis, insights, and strategies to pursue value-driven solutions.

In a phase 2 trial, a gene therapy reduced angioedema attacks, which could significantly change the quality of life for ...

Kebilidi is a one-time gene therapy administered directly to the brain in patients with AADC deficiency, rare genetic ...

In a new study of patients with metastatic non-small cell lung cancer, researchers found that patients who were more physically fit had better outcomes. With lung cancer claiming around 1.8 million ...

Managed Healthcare Executive provides C-suite executives at health plans and provider organizations with news, analysis, ...

In this latest episode of Tuning In to the C-Suite podcast, Briana Contreras, an editor with MHE had the pleasure of meeting ...

The panelist discusses how intrauterine insemination is typically considered for patients with unexplained infertility, mild ...

Seemal Desai, M.D., FAAD, discusses how immune system dysregulation and genetic variants intersect to trigger vitiligo development while highlighting diagnostic challenges including identifying ...

Managed Healthcare Executive provides C-suite executives at health plans and provider organizations with news, analysis, insights, and strategies to pursue value-driven solutions.

People with multiple sclerosis (MS) often stop taking disease-modifying therapy as they transition from relapsing-remitting MS to secondary progressive MS. This study shows that people who stop stop ...